Guideline on the management of haemophilia in the fetus and neonate

British Journal of Haematology

Volumn 154, Issue 2, 2011, Pages 208-215

  Chalmers, Elizabeth ^a   Williams, Michael ^b   Brennand, Janet ^c   Liesner, Ri ^d   Collins, Peter ^e   Richards, Michael ^f  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^c SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^d GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^e UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^f ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Bleeding disorders; Fetal medicine; Haemophilia; Neonatal haematology; Pregnancy

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; DESMOPRESSIN; FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 8; RECOMBINANT BLOOD CLOTTING FACTOR 9; VITAMIN K GROUP;

AMNIOCENTESIS; ARTICLE; BLOOD EXAMINATION; BRAIN HEMORRHAGE; CESAREAN SECTION; DELAYED DIAGNOSIS; EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; FAMILIAL DISEASE; FETUS; FORCEPS DELIVERY; GENETIC SCREENING; GESTATION PERIOD; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HETEROZYGOTE; HIGH RISK PATIENT; HUMAN; HYPONATREMIA; MATERNAL CARE; NEWBORN; NEWBORN CARE; PARTIAL THROMBOPLASTIN TIME; PRACTICE GUIDELINE; PREMATURITY; PRENATAL CARE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RADIODIAGNOSIS; RISK REDUCTION; SEX DETERMINATION; VAGINAL DELIVERY;

CEREBRAL HEMORRHAGE; DELIVERY, OBSTETRIC; EARLY DIAGNOSIS; EVIDENCE-BASED MEDICINE; FEMALE; FETAL DISEASES; HEMOPHILIA A; HUMANS; INFANT, NEWBORN; MALE; PERINATAL CARE; PREGNANCY; PRENATAL CARE;

EID: 79959850420     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08545.x     Document Type: Article

References (45)

1. Abshire, T., Shapiro, A., Gill, J., Pasi, J. & Courter, S.; and the Recombinant Factor IX Study Group (1998) Recombinant Factor IX in the treatment of previously untreated patients (PUPs) with severe or moderately severe haemophilia B. Haemophilia, 4, 229.
2. Andrew, M., Paes, B., Milner, R., Johnson, M., Mitchell, L., Tollefsen, D.M. & Powers, P. (1987) Development of the coagulation system in the full-term infant. Blood, 70, 165-172.
3. Andrew, M., Paes, B., Milner, R., Johnston, M., Mitchell, L., Tollefsen, D.M., Castle, V. & Powers, P. (1988) Development of the human coagulation system in the healthy premature infant. Blood, 80, 1998-2005.
4. Atkins, D., Best, D., Briss, P.A., Eccles, M., Falck-Ytter, Y., Flottorp, S., Guyatt, G.H., Harbour, R.T., Haugh, M.C., Henry, D., Hill, S., Jaeschke, R., Leng, G., Liberati, A., Magrini, N., Mason, J., Middleton, P., Mrukowicz, J., O'Connell, D., Oxman, A.D., Phillips, B., Schünemann, H.J., Edejer, T.T., Varonen, H., Vist, G.E., Williams, Jr, J.W. & Zaza, S.; Grade Working Group (2004) Grading quality of evidence and strength of recommendations. BMJ, 328, 1490-1494.
5. Bidlingmaier, C., Bergmann, F. & Kurnik, K. (2005) Haemophilia A in two premature infants. European Journal of Pediatrics, 164, 70-72.
6. Bustamante-Aragones, A., Rodriguez de Alba, M., Gonzalez-Gonzalez, C., Trujillo- Tiebas, M.J., Diego-Alvarez, D., Vallespin, E., Plaza, J., Ayuso, C. & Ramos, C. (2008) Foetal sex determination in maternal blood from seventh week of gestation and its role in diagnosing haemophilia in the foetuses of female carriers. Haemophilia, 14, 593-598.
7. Chalmers, E.A., Williams, M.D., Richards, M., Brown, S.A., Liesner, R., Thomas, A., Vidler, V., Pasi, K.J. & Hill, F.G.; Paediatric Working Party of UKHCDO (2005) Management of neonates with inherited bleeding disorders - a survey of current UK practice. Haemophilia, 11, 186-187.
8. Chalmers, E.A., Brown, S.A., Keeling, D., Liesner, R., Richards, M., Stirling, D., Thomas, A., Vidler, V., Williams, M.D. & Young, D.; Paediatric Working Party of UKHCDO (2007) Early factor VIII exposure and subsequent inhibitor development in children with severe haemophilia A. Haemophilia, 13, 149-155.
9. Conway, J.H. & Hilgarter, M.W. (1994) Initial presentation of paediatric hemophiliacs. Archives of Pediatrics and Adolescent Medicine, 148, 589-594.
10. Cornelissen, M., von Kries, R., Loughnan, P. & Schubiger, G. (1997) Prevention of vitamin K deficiency bleeding: efficacy of different multiple oral dose schedules of vitamin K. European Journal of Pediatrics, 156, 126-130.
11. Dunkley, S.M., Russell, S.J., Rowell, J.A., Barnes, C.D., Baker, R.I., Sarson, M.I. & Street, A.M.; on behalf of the Australian Haemophilia Centre Directors Organisation (2009) A consensus statement on the management of pregnancy and delivery in women who are carriers of or have bleeding disorders. Medical Journal of Australia, 191, 460-463.
12. Gale, R.F., Hird, M.F. & Colvin, B.T. (1998) Management of a premature infant with moderate haemophilia A using recombinant factor VIII. Haemophilia, 4, 850-853.
13. Giannelli, F. & Green, P.M. (1996) The molecular basis of haemophilia A and B. Baillière's Clinical Haematology, 9, 211-228.
14. Gouw, S.C., van der Bom, J.G. & van den Berg, H.M. (2007) Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study. Blood, 109, 4648-4654.
15. Guilcher, G.M., Scully, M.F., Harvey, M. & Hand, J.P. (2005) Treatment of intracranial and extracranial haemorrhages in a neonate with severe haemophilia B with recombinant factor IX infusion. Haemophilia, 11, 411-414.
16. Guyatt, G.H., Oxman, A.D., Vist, G.E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P. & Schünemann, H.J. (2008a) GRADE: an emerging concensus on rating quality of evidence and strength of recommendations. BMJ, 336, 924-926.
17. Guyatt, G.H., Oxman, A.D., Kunz, R., Falck-Ytter, Y., Vist, G.E., Liberati, A. & Schünemann, H.J. (2008b) GRADE: going from evidence to recommendations. BMJ, 336, 1049-1051.
18. Haemostasis and Thrombosis Task Force (1994) Investigation and management of haemorrhagic disorders in pregnancy. Journal of Clinical Pathology, 47, 100-108.
19. James, A.H. & Hoots, K. (2010) The optimal mode of delivery for the haemophilia carrier expecting an affected infant is caesarean delivery. haemophilia, 16, 420-424.
20. Keeling, D., Tait, C. & Makris, M. (2008) Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. Haemophilia, 14, 671-684.
21. Klinge, J., Auberger, K., Auerswald, G., Brackmann, H.H., Mauz-Korholz, C. & Kreuz, W. (1999) Prevalence and outcome of intracranial haemorrhage in haemophilacs - a survey of the paediatric group of the German Society for Thrombosis and Haemostasis (GTH). European Journal of Pediatrics, 158, S162-S165.
22. Kraft, K.E., Verlaak, R., van Heijst, A.F.J., Novakova, I. & Brons, P.P.T. (2008) Management of haemophilia in three premature infants. Haemophilia, 14, 378-380.
23. Kulkarni, R. & Lusher, J.M. (1999) Intracranial and extracranial hemorrhages in newborns with hemophilia. Journal of Pediatric Hematology/oncology, 21, 289-295.
24. Kulkarni, R., Lusher, J.M., Henry, R.C. & Kallens, D.J. (1999) Current practices regarding new-born intracranial haemorrhage and obstetrical care and mode of delivery of pregnant haemophilia carriers: a survey of obstetricians, neonatologists and haematologists in the United States, on behalf of the National Hemophilia Foundation's Medical and Scientific Advisory Council. Haemophilia, 5, 410-415.
25. Kulkarni, R., Soucie, J.M., Lusher, J., Presley, R., Shapiro, A., Gill, J., Manco-Johnson, M., Koerper, M., Mathew, P., Abshire, T., DiMichelle, D., Hoots, K., Janco, R., Nugent, D., Geraghty, S. & Evatt, B. (2009) Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2years: report from the disease control and prevention's (CDC) universal data collection project. Haemophilia, 15, 1281-1290.
26. Lavery, S. (2009) Preimplantation genetic diagnosis of haemophilia. British Journal of Haematology, 144, 303-307.
27. Lee, C.A., Chi, C., Pavord, S.R., Bolton- Maggs, P.H.B., Pollard, D., Hinchcliffe-Wood, A. & Kadir, R.A. (2006) The obstetric and gynaecological management of women with inherited bleeding disorders - review with guidelines produced by a task force of UK Haemophilia Centre Doctors' Organisation. Haemophilia, 12, 301-336.
28. Ljung, R. (2010) The optimal mode of delivery for the haemophilia carrier expecting an affected infant is vaginal delivery. Haemophilia, 16, 415-419.
29. Ljung, R., Lindgren, A.C., Patrini, P. & Tengborn, L. (1994) Normal vaginal delivery is recommended for hemophilia carrier gravidae. Acta Paediatrica, 83, 609-611.
30. Lorenzo, J.I., Lopez, A., Altisent, C. & Aznar, J.A. (2001) Incidence of factor VIII inhibitos in severe haemophilia: the importance of patient age. British Journal of Haematology, 113, 600-603.
31. Ludlam, C.A., Pasi, K.J., Bolton-Maggs, P., Collins, P.W., Cumming, A.M., Dolan, G., Fryer, A., Harrington, C., Hill, F.G., Peake, I.R., Perry, D.J., Skirton, H. & Smith, M.; UK Haemophilia Centre Doctors' Organisation (2005) A framework for genetic service provision for haemophilia and other inherited bleeding disorders. Haemophilia, 11, 145-163.
32. MacLean, P.E., Fijnvandraat, K., Beijlevelt, M. & Peters, M. (2004) The impact of unaware carriership on the clinical presentation of haemophilia. haemophilia, 10, 560-564.
33. Medical and Scientific Advisory Council (MASAC) of the National haemophilia Foundation (2009) MASAC guidelines for perinatal management of women with bleeding disorders and carriers of haemophilia A and B.
34. Plauche, W.C. (1980) Subgaleal hematoma. A complication of instrumental delivery. JAMA, 244, 1597-1598.
35. Poon, M.C., Lillicrap, D., Hensman, C., Card, R. & Scully, M.F. (2002) Recombinant factor IX recovery and inhibitor safety: a Canadian post-licensure surveillance study. Thrombosis Haemostasis, 87, 431-435.
36. Richards, M., Fijnvandraat, K. & Lavigne-Lissalde, G. (2009) A European study of major neoanatal haemorrhage in haemophilia. Journal of Thrombosis and Haemostasis, 7(Suppl S2), 99.
37. Rickard, K.A. (1995) Guidelines for therapy and optimal dosages of coagulation factors fro treatment of bleeding and surgery in haemophilia. Haemophilia, 1(Suppl.1), 8-13.
38. Royal College of Obstetricians and Gynaecologists (2005) Operative vaginal delivery. Guideline No.26. London: RCOG.
39. Royal College of Obstetricians and Gynaecologists (2010) Amniocentesis and chorionic villus sampling. Guideline No.8 (revised). London: RCOG.
40. Smith, A.R., Leonard, N. & Kurth, M.H. (2008) Intracranial hemorrhage in newborns with hemophilia: the role of screening radiologic studies in the first 7days of life. Journal of Pediatric Hematology/oncology, 30, 81-84.
41. Stieltjes, N., Calvez, T., Demiguel, V., Torchet, M.F., Briquel, M.E., Fressinaud, E., Claeyssens, S., Coatmelec, B. & Chambost, H.; and The French ICH Study Group (2005) Intracranial haemorrhages in French haemophilia patients (1991-2001): clinical presentation, management and prognosis factors for death. Haemophilia, 11, 452-458.
42. Tarantino, M.D., Gupta, S.L. & Brusky, R.M. (2007) The incidence and outcome of intracranial haemorrhage in newborns with haemophilia: analysis of the nationwide inpatient sample database. Haemophilia, 13, 380-382.
43. Towner, D., Castro, M.A., Eby-Wilkens, E. & Gilbert, W.M. (1995) Effect of mode of delivery in nulliparous women on neonatal intracranial injury. New England Journal of Medicine, 341, 1709-1714.
44. Van der Bom, J.G., Mauser-Bunschoten, P., Fischer, K. & van den Berg, H.M. (2003) Age at first treatment and immune tolerance to factor VIII in severe hemophilia. Thrombosis and Haemostasis, 98, 475-479.
45. Whitby, E.H., Griffiths, P.D., Rutter, S., Smith, M.F., Sprigg, A., Ohadike, P., Davies, N.P., Rigby, A.S. & Paley, M.N. (2003) Frequency and natural history of subdural haemorrhages in babies and relation to obstetric factors. Lancet, 363, 846-851.